Chase C. Leavitt

Chase C. Leavitt is a declared insider at 2 companies; the most frequent names are Oncternal Therapeutics, Inc. and Mobia Medical, Inc. The record holds 9 filings, for trades running from 11 June 2021 to 11 September 2026.

On the market, this insider has only ever bought: 4 purchases, €42k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants. 2026 to date brings 1 purchase and no sales.

Half of the purchases are above €10k and half below. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

On 15 September 2026 came the latest disclosure, an open-market purchase for €18k in Mobia Medical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.